HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Penile cancer

Penile cancer is a rare form of cancer that affects the tissues of the penis. It typically originates in the cells of the skin or glands of the penis and may present as a lump or sore on the genital area. This type of cancer is more common in older men, typically over the age of 60, but it can occur at any age. The exact cause of penile cancer is not well understood, but certain risk factors may increase the likelihood of its development. These include a history of human papillomavirus (HPV) infection, smoking, lack of circumcision, and poor genital hygiene. Regular medical check-ups and early detection are crucial in managing and treating penile cancer effectively. Symptoms of penile cancer may include changes in the color or thickness of the skin on the penis, the development of a lump or ulcer, and persistent itching or tenderness. If any of these symptoms are noticed, it is essential to seek prompt medical attention for a thorough evaluation. Diagnosis often involves a physical examination, biopsy, and imaging tests to determine the extent of the cancer. Treatment options vary based on the stage of the cancer but may include surgery, radiation therapy, and chemotherapy. The choice of treatment is influenced by factors such as the size and location of the tumor, as well as the overall health of the individual. As with many types of cancer, prevention plays a crucial role. Practicing safe sex, maintaining good genital hygiene, and receiving the HPV vaccine are essential measures to reduce the risk of developing penile cancer. It is crucial for individuals to be aware of their bodies, report any unusual changes to a healthcare professional, and participate in routine screenings to catch potential issues early on. Penile cancer, while relatively uncommon, emphasizes the importance of overall health awareness and proactive healthcare practices.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp